CareFusion Corporation  

(Public, NYSE:CFN)   Watch this stock  
Find more results for Joan B. Gordon
44.73
-0.28 (-0.62%)
Jul 29 - Close
NYSE real-time data - Disclaimer
Currency in USD
Range 44.70 - 45.11
52 week 35.01 - 45.81
Open 45.00
Vol / Avg. 0.00/1.23M
Mkt cap 9.27B
P/E 24.94
Div/yield     -
EPS 1.79
Shares 207.31M
Beta 0.93
Inst. own 94%

Key stats and ratios

Q1 (Mar '14) 2013
Net profit margin 10.54% 10.96%
Operating margin 16.43% 17.44%
EBITD margin - 24.28%
Return on average assets 4.73% 4.57%
Return on average equity 7.61% 7.33%
Employees 15,000 -
CDP Score - -

Address

3750 Torrey View Court
SAN DIEGO, CA 92130
United States - Map
+1-858-6172000 (Phone)
+1-302-6555049 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

CareFusion Corporation (CareFusion) is a global medical technology company. The Company operates in two segments: Medical Systems and Procedural Solutions. The Medical Systems segment is organized around its medical equipment businesses. The Company�s Medical Systems segment�s business units and product lines include Infusion Systems, Dispensing Technologies, and Respiratory Technologies. The Procedural Solutions segment is organized around the Company�s disposable products and reusable surgical instruments businesses. The Company�s Procedural Solutions segment�s business units and product lines include Infection Prevention, Medical Specialties and Specialty Disposables. In June 2012, the Company acquired U.K. Medical Limited. In July 2012, Natus Medical, Inc. acquired the Nicolet neurodiagnostic business from CareFusion. Effective December 31, 2013, CareFusion Corp acquired Vital Signs Inc from GE Healthcare, a unit of General Electric Co.

Officers and directors

Kieran T. Gallahue Chairman of the Board, Chief Executive Officer
Age: 50
Bio & Compensation  - Reuters
James F. Hinrichs Chief Financial Officer
Age: 46
Bio & Compensation  - Reuters
Thomas J. Leonard President - Medical Systems
Age: 45
Bio & Compensation  - Reuters
Joan B. Stafslien Executive Vice President, Chief Compliance Officer, General Counsel, Secretary
Age: 49
Bio & Compensation  - Reuters
Roger Marchetti Executive Vice President - Human Resources
Age: 55
Bio & Compensation  - Reuters
Donald Abbey Executive Vice President - Quality, Regulatory and Medical Affairs
Age: 46
Bio & Compensation  - Reuters
Gordon La Fortune Executive Vice President - EMEA/APAC Commercial Operations and Global Infusion Disposables
Age: 56
Bio & Compensation  - Reuters
Jonathan Wygant Senior Vice President, Chief Accounting Officer, Controller
Age: 42
Bio & Compensation  - Reuters
Supratim Bose Independent Director
Age: 61
Bio & Compensation  - Reuters
Philip L. Francis Non-Employee Independent Director
Age: 66
Bio & Compensation  - Reuters